National Vision vs Warby Parker
EYE and WRBY side by side, both in measuring, analyzing, and controlling instruments; photographic, medical and optical goods; watches and clocks. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How EYE and WRBY compare
Warby Parker is the larger company, worth 2.3 times as much as National Vision ($3.0B against $1.3B).
On earnings, National Vision is cheaper: it trades at 27.2× trailing earnings, against 352× for Warby Parker.
Warby Parker grew revenue faster over the last twelve months (11.0% versus 7.8% for National Vision).
National Vision keeps more of each dollar of sales as profit, with a net margin of 2.5% compared with 0.85% at Warby Parker.
National Vision scores higher on the StockData Score (13 against 11 for Warby Parker), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | EYE | WRBY |
|---|---|---|
| Size and price | ||
| Market cap | $1.3B | $3.0B |
| Share price | $16.59 | $24.61 |
| Change, 1 year | −38.6% | 22.7% |
| Change, 5 years | −74.5% | −57.1% |
| Beta (5Y) | 0.98 | 1.90 |
| Employees | 13K | 4,036 |
| StockData Score | ||
| Total score | 13 (better) | 11 |
| Valuation score | 6 (better) | 0 |
| Growth score | 1 | 3 (better) |
| Performance score | 3 (better) | 2 |
| Health score | 3 | 6 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | 27.2× (better) | 352× |
| P/S | 0.6× (better) | 3.3× |
| P/B | 1.5× (better) | 7.8× |
| EV/EBITDA | 8.6× (better) | 50.0× |
| P/FCF | 26.7× (better) | 140× |
| FCF yield | 3.7% (better) | 0.71% |
| Fair value | $23.82 | $9.45 |
| Margin of safety | 30.4% (better) | −160% |
| Growth | ||
| Revenue growth (TTM) | 7.8% | 11.0% (better) |
| Revenue growth, 5Y average | 3.0% | 17.2% (better) |
| EPS growth, 5Y average | −3.4% | – |
| Profitability | ||
| Gross margin | 58.6% (better) | 54.7% |
| Operating margin | 4.1% (better) | 0.17% |
| Net margin | 2.5% (better) | 0.85% |
| FCF margin | 2.4% (better) | 2.4% |
| Return on equity | 5.8% (better) | 2.1% |
| Return on invested capital | 5.7% (better) | 1.4% |
| Financial health | ||
| Debt / equity | 0.26 (better) | 0.00 |
| Net debt / EBITDA | 1.11 | – |
| Current ratio | 0.59 | 2.27 (better) |
| Altman Z-score | 2.00 | 5.08 (better) |
| Piotroski F-score | 8 (better) | 5 |
| Dividends and buybacks | ||
| Buyback yield | 2.4% | – |
| Shareholder yield | 2.4% (better) | 0.00% |
| Ownership | ||
| Held by institutions | 126% | 101% |
| Held by insiders | 2.5% | 17.3% |
| Insider net buying, 12 months | −$498K (better) | −$47.1M |
| Superinvestors holding | 1 | 2 (better) |
| Short interest, % of float | 20.2% | 17.8% |
Go deeper
- EYE stock overview
- EYE income statement
- EYE valuation and score
- WRBY stock overview
- WRBY income statement
- WRBY valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.